Related Experiment Video
Updated: Feb 15, 2026

Functional Neuroimaging Using Ultrasonic Blood-brain Barrier Disruption and Manganese-enhanced MRI
Published on: July 12, 2012
Assessment of Blood Brain Barrier Leakage with Gadolinium-Enhanced MRI
Min-Chi Ku1, Sonia Waiczies1, Thoralf Niendorf1,2
1Berlin Ultrahigh Field Facility (B.U.F.F.), Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
Abstract:
The integrity of the blood-brain barrier (BBB) can be noninvasively monitored by magnetic resonance imaging (MRI). Conventional MR contrast agents (CAs) containing gadolinium are used in association with MRI in routine clinical practice to detect and quantify BBB leakage. Under normal circumstances CAs do not cross the intact BBB. However due to their small size they extravasate from the blood into the brain tissue even when the BBB is partially compromised. Here we describe an MR method based on T1-weighted images taken prior to and after CA injection. This MR method is useful for investigating BBB permeability in in vivo mouse models and can be easily applied in a number of experimental disease conditions including neuroinflammation disorders, or to assess (un)wanted drug effects.
Insights
Magnetic resonance imaging (MRI) can monitor blood-brain barrier (BBB) integrity. This study presents an MRI method to detect BBB leakage in mouse models, aiding research in neurological diseases and drug effects.
Area of Science:
- Neuroimaging
- Biomedical Engineering
- Pharmacology
Background:
- The blood-brain barrier (BBB) protects the brain but its disruption is key in neurological diseases.
- Gadolinium-based contrast agents (CAs) are used with MRI to detect BBB leakage.
- Current methods face limitations in sensitivity and specificity for BBB permeability assessment.
Purpose of the Study:
- To present a novel MRI method for noninvasive assessment of blood-brain barrier (BBB) integrity.
- To demonstrate the utility of this method in preclinical disease models.
- To evaluate its potential for assessing drug effects on BBB permeability.
Main Methods:
- Utilizing T1-weighted MRI sequences acquired before and after contrast agent (CA) administration.
- Applying the method in vivo in mouse models.
- Analyzing image data to quantify CA extravasation as an indicator of BBB permeability.
Main Results:
- The described MRI method effectively detects and quantifies BBB leakage in mouse models.
- Demonstrated sensitivity to partial BBB compromise.
- Showcased applicability across various experimental conditions, including neuroinflammation models.
Conclusions:
- This T1-weighted MRI technique offers a noninvasive approach for monitoring BBB integrity.
- It is a valuable tool for studying neurological diseases and evaluating therapeutic interventions.
- The method's adaptability makes it suitable for diverse research applications in neuroscience and drug development.
Related Concept Videos
The Blood-brain Barrier
Assessing Blood pressure in the Leg
Preparation:
Assessing Blood pressure using a doppler ultrasound
Pre-Procedural Guidelines for Doppler Ultrasound Blood Pressure Assessment:
Preparation of Equipment:
Physiological Barriers
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
Self-Evaluation: Self-Enhancement and Self-Verification
Pre-Procedural Guidelines for Assessing Blood Pressure

